Paper · 20652370
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.
Stang A. Eur J Epidemiol, 2010. Cited by 15,150 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Papers, record 20652370. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20652370
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clinical Trials as Topic | Major topic |
| Meta-Analysis as Topic | Major topic |
| Case-Control Studies | |
| Cohort Studies | |
| Humans | |
| Validation Studies as Topic |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,690,747 | An empirical investigation on matching in published case-control studies. | Eur J Epidemiol | 1998 | https://conductscience.org/library/papers/9690747 | PubMed |
| 2 | 14,499,048 | Evaluating non-randomised intervention studies. | Health Technol Assess | 2003 | https://conductscience.org/library/papers/14499048 | PubMed |
| 3 | 10,493,204 | The hazards of scoring the quality of clinical trials for meta-analysis. | JAMA | 1999 | https://conductscience.org/library/papers/10493204 | PubMed |
| 4 | 17,470,488 | Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. | Int J Epidemiol | 2007 | https://conductscience.org/library/papers/17470488 | PubMed |
| 5 | 10,789,670 | Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. | JAMA | 2000 | https://conductscience.org/library/papers/10789670 | PubMed |
| 6 | 18,480,607 | Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. | Cerebrovasc Dis | 2008 | https://conductscience.org/library/papers/18480607 | PubMed |
| 7 | 16,443,797 | Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany). | Am J Epidemiol | 2006 | https://conductscience.org/library/papers/16443797 | PubMed |
| 8 | 7,246,521 | The effect of response bias on the odds ratio. | Am J Epidemiol | 1981 | https://conductscience.org/library/papers/7246521 | PubMed |
| 9 | 19,826,127 | Mobile phone use and risk of tumors: a meta-analysis. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19826127 | PubMed |
Cited by9,751
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15,150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,989,401 | The association between stress hyperglycemia ratio and adverse outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. | Diabetol Metab Syndr | 2026 | https://conductscience.org/library/papers/42989401 | PubMed |
| 42,985,635 | Efficacy and Safety of Bioresorbable Vascular Scaffolds Versus Contemporary Drug-Eluting Stents in Coronary Artery Disease: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42985635 | PubMed |
| 42,985,168 | The efficacy of taurolidine lock solution in preventing catheter-related bloodstream infections in pediatrics: a systematic review and meta-analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42985168 | PubMed |
| 42,984,559 | Perioperative safety profile of robotic versus laparoscopic hiatal hernia repair: a systematic review and meta-analysis. | Front Surg | 2026 | https://conductscience.org/library/papers/42984559 | PubMed |
| 42,983,457 | Association of the triglyceride-glucose index with prostate cancer risk and prognosis: a systematic review and meta-analysis. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42983457 | PubMed |
| 42,983,433 | Efficacy and safety of regorafenib plus PD-1/PD-L1 inhibitors for metastatic colorectal cancer: a systematic review and meta-analysis. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42983433 | PubMed |
| 42,982,805 | Meta-analysis of empirical evidence on biodiversity and the risk of asthma. | Nat Commun | 2026 | https://conductscience.org/library/papers/42982805 | PubMed |
| 42,979,094 | Efficacy and safety of local vs. systemic steroid therapy for patients with sudden deafness and diabetes mellitus: A systematic review and meta-analysis. | Biomed Rep | 2026 | https://conductscience.org/library/papers/42979094 | PubMed |
| 42,978,691 | Association between CISD2 expression and clinicopathological features and prognosis in gastric cancer: a systematic review, meta-analysis, and database validation. | Front Oncol | 2026 | https://conductscience.org/library/papers/42978691 | PubMed |
| 42,975,717 | Oncologic efficacy and safety of stereotactic body radiotherapy for oligometastatic non-small cell lung cancer: a systemic meta-analysis. | Clin Exp Metastasis | 2026 | https://conductscience.org/library/papers/42975717 | PubMed |
1 to 10 of 9,751
See all 9,751 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20652370
GET https://conductscience.org/api/papers/v1/20652370/cited_by?page=2